These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 27881216)

  • 1. Interacting network of Hippo, Wnt/β-catenin and Notch signaling represses liver tumor formation.
    Kim W; Khan SK; Yang Y
    BMB Rep; 2017 Jan; 50(1):1-2. PubMed ID: 27881216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hippo signaling interactions with Wnt/β-catenin and Notch signaling repress liver tumorigenesis.
    Kim W; Khan SK; Gvozdenovic-Jeremic J; Kim Y; Dahlman J; Kim H; Park O; Ishitani T; Jho EH; Gao B; Yang Y
    J Clin Invest; 2017 Jan; 127(1):137-152. PubMed ID: 27869648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammalian sterile 20-like kinase 1/2 inhibits the Wnt/β-catenin signalling pathway by directly binding casein kinase 1ε.
    Xu F; Wang YL; Chang JJ; Du SC; Diao L; Jiang N; Wang HJ; Ma D; Zhang J
    Biochem J; 2014 Feb; 458(1):159-69. PubMed ID: 24180524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activation.
    Abitbol S; Dahmani R; Coulouarn C; Ragazzon B; Mlecnik B; Senni N; Savall M; Bossard P; Sohier P; Drouet V; Tournier E; Dumont F; Sanson R; Calderaro J; Zucman-Rossi J; Vasseur-Cognet M; Just PA; Terris B; Perret C; Gilgenkrantz H
    J Hepatol; 2018 Jun; 68(6):1203-1213. PubMed ID: 29525529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic Hippo signaling inhibits protumoural microenvironment to suppress hepatocellular carcinoma.
    Kim W; Khan SK; Liu Y; Xu R; Park O; He Y; Cha B; Gao B; Yang Y
    Gut; 2018 Sep; 67(9):1692-1703. PubMed ID: 28866620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TBX3 functions as a tumor suppressor downstream of activated CTNNB1 mutants during hepatocarcinogenesis.
    Liang B; Zhou Y; Qian M; Xu M; Wang J; Zhang Y; Song X; Wang H; Lin S; Ren C; Monga SP; Wang B; Evert M; Chen Y; Chen X; Huang Z; Calvisi DF; Chen X
    J Hepatol; 2021 Jul; 75(1):120-131. PubMed ID: 33577921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Crosstalk of Hippo/YAP and Wnt/β-catenin pathways].
    Xu F; Zhang J; Ma D
    Yi Chuan; 2014 Feb; 36(2):95-102. PubMed ID: 24846937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MEIS2C and MEIS2D promote tumor progression via Wnt/β-catenin and hippo/YAP signaling in hepatocellular carcinoma.
    Guan L; Li T; Ai N; Wang W; He B; Bai Y; Yu Z; Li M; Dong S; Zhu Q; Ding XX; Zhang S; Li M; Tang G; Xia X; Zhao J; Lin S; Yao S; Zhang L; Chen G; Liu FE; Li X; Zhang H
    J Exp Clin Cancer Res; 2019 Oct; 38(1):417. PubMed ID: 31623651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morin impedes Yap nuclear translocation and fosters apoptosis through suppression of Wnt/β-catenin and NF-κB signaling in Mst1 overexpressed HepG2 cells.
    Perumal N; Perumal M; Kannan A; Subramani K; Halagowder D; Sivasithamparam N
    Exp Cell Res; 2017 Jun; 355(2):124-141. PubMed ID: 28366538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Notch activity characterizes a common hepatocellular carcinoma subtype with unique molecular and clinicopathologic features.
    Zhu C; Ho YJ; Salomao MA; Dapito DH; Bartolome A; Schwabe RF; Lee JS; Lowe SW; Pajvani UB
    J Hepatol; 2021 Mar; 74(3):613-626. PubMed ID: 33038431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Notch and Wnt/β-catenin signaling pathway play important roles in activating liver cancer stem cells.
    Wang R; Sun Q; Wang P; Liu M; Xiong S; Luo J; Huang H; Du Q; Geller DA; Cheng B
    Oncotarget; 2016 Feb; 7(5):5754-68. PubMed ID: 26735577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential requirement of Hippo cascade during CTNNB1 or AXIN1 mutation-driven hepatocarcinogenesis.
    Liang B; Wang H; Qiao Y; Wang X; Qian M; Song X; Zhou Y; Zhang Y; Shang R; Che L; Chen Y; Huang Z; Wu H; Monga SP; Zeng Y; Calvisi DF; Chen X; Chen X
    Hepatology; 2023 Jun; 77(6):1929-1942. PubMed ID: 35921500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Hippo pathway regulates Wnt/beta-catenin signaling.
    Varelas X; Miller BW; Sopko R; Song S; Gregorieff A; Fellouse FA; Sakuma R; Pawson T; Hunziker W; McNeill H; Wrana JL; Attisano L
    Dev Cell; 2010 Apr; 18(4):579-91. PubMed ID: 20412773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic STRAP Supports Hepatocellular Carcinoma Growth by Enhancing Wnt/β-Catenin Signaling.
    Wang W; Li S; Liu P; Sideras K; van de Werken HJG; van der Heide M; Cao W; Lavrijsen M; Peppelenbosch MP; Bruno M; Pan Q; Smits R
    Mol Cancer Res; 2019 Feb; 17(2):521-531. PubMed ID: 30257989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulation of Wnt/β-catenin signaling by protein kinases in hepatocellular carcinoma and its therapeutic application.
    Li Q; Sun M; Wang M; Feng M; Yang F; Li L; Zhao J; Chang C; Dong H; Xie T; Chen J
    Cancer Sci; 2021 May; 112(5):1695-1706. PubMed ID: 33605517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrin α2β1 inhibits MST1 kinase phosphorylation and activates Yes-associated protein oncogenic signaling in hepatocellular carcinoma.
    Wong KF; Liu AM; Hong W; Xu Z; Luk JM
    Oncotarget; 2016 Nov; 7(47):77683-77695. PubMed ID: 27765911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of hepatic stem cell marker EpCAM by Wnt-beta-catenin signaling in hepatocellular carcinoma.
    Yamashita T; Budhu A; Forgues M; Wang XW
    Cancer Res; 2007 Nov; 67(22):10831-9. PubMed ID: 18006828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Yes-associated protein up-regulates Jagged-1 and activates the Notch pathway in human hepatocellular carcinoma.
    Tschaharganeh DF; Chen X; Latzko P; Malz M; Gaida MM; Felix K; Ladu S; Singer S; Pinna F; Gretz N; Sticht C; Tomasi ML; Delogu S; Evert M; Fan B; Ribback S; Jiang L; Brozzetti S; Bergmann F; Dombrowski F; Schirmacher P; Calvisi DF; Breuhahn K
    Gastroenterology; 2013 Jun; 144(7):1530-1542.e12. PubMed ID: 23419361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 4-Acetylantrocamol LT3, a New Ubiquinone from
    Chen YL; Yen IC; Lin KT; Lai FY; Lee SY
    Am J Chin Med; 2020; 48(5):1243-1261. PubMed ID: 32668963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic Hippo signaling inhibits development of hepatocellular carcinoma.
    Liu Y; Wang X; Yang Y
    Clin Mol Hepatol; 2020 Oct; 26(4):742-750. PubMed ID: 32981290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.